Prevalence and Associated Factors of Pseudoexfoliation in a Russian Population: The Ural Eye and Medical Study

To assess the prevalence of pseudoexfoliation (PEX) and its associations in a Russian population. Population-based cross-sectional study. Setting: Ufa capital of Bashkortostan, Russia and a rural region in Bashkortostan. the Ural Eye and Medical Study included 5,899 (80.5%) of 7,328 eligible individ...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:American journal of ophthalmology Ročník 210; s. 158 - 166
Hlavní autori: Bikbov, Mukharram M., Zainullin, Rinat M., Gilmanshin, Timur R., Kazakbaeva, Gyulli M., Yakupova, Dilya F., Nuriev, Ildar F., Zaynetdinov, Artur F., Khalimov, Timur A., Panda-Jonas, Songhomitra, Uzianbaeva, Yulia V., Rakhimova, Ellina M., Rusakova, Iulia A., Salavatova, Venera F., Arslangareeva, Inga I., Bikbova, Guzel M., Nikitin, Nikolay A., Jonas, Jost B.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States Elsevier Inc 01.02.2020
Elsevier Limited
Predmet:
ISSN:0002-9394, 1879-1891, 1879-1891
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract To assess the prevalence of pseudoexfoliation (PEX) and its associations in a Russian population. Population-based cross-sectional study. Setting: Ufa capital of Bashkortostan, Russia and a rural region in Bashkortostan. the Ural Eye and Medical Study included 5,899 (80.5%) of 7,328 eligible individuals (mean age, 59.0 ± 10.7 years old; range, 40-94 years). Observation procedures: as part of an ophthalmological and general examination, presence and degree of PEX was assessed using slit-lamp biomicroscopy after medical pupillary dilation. Main outcome measurements: PEX prevalence. After excluding pseudophakic and aphakic individuals, the study included 5,451 (92.4%) participants. PEX prevalence (3.6%; 95% confidence interval [CI]:3.1-4.1), increased from 0.5% (95% CI, 0.1-0.9) in individuals 40 to <50 years old to 10.4% (95% CI, 5.0-15.8) in individuals aged 80+ years. Higher PEX prevalence was associated (multivariate analysis) with older age (odds ratio [OR], 1.09; 95% CI, 1.07-1.11; P < 0.001), Russian ethnicity (OR, 1.50; 95% CI, 2.09-1.11;P = 0.02), higher prevalence of open-angle glaucoma (OR, 2.40; 95% CI, 1.36-4.23;P = 0.003), and higher intraocular pressure (OR, 1.06; 95% CI, 1.02-1.09;P = 0.001). PEX prevalence was not significantly associated with gender (P = 0.49), region of habitation (P = 0.11), body mass index (P = 0.68), level of education (P = 0.26), smoking (P = 0.11), alcohol consumption (P = 0.52), history of cardiovascular or cerebrovascular disease (P = 0.94) and dementia (P = 0.77), prevalence of diabetes mellitus (P = 0.16), arterial hypertension (P = 0.45), chronic obstructive pulmonary disease (P = 0.73), chronic kidney disease (P = 0.09), and hearing loss (P = 0.31). In this typical, ethnically mixed, population from Russia with an age of 40+ years, PEX prevalence (3.6%; 95% CI, 3.1-4.1) was associated with older age, Russian ethnicity, higher intraocular pressure and open-angle glaucoma. It was independent of any systemic parameter including diabetes, arterial hypertension, previous cardiovascular and cerebrovascular diseases and dementia.
AbstractList PurposeTo assess the prevalence of pseudoexfoliation (PEX) and its associations in a Russian population.DesignPopulation-based cross-sectional study.MethodsSetting: Ufa capital of Bashkortostan, Russia and a rural region in Bashkortostan.Participantsthe Ural Eye and Medical Study included 5,899 (80.5%) of 7,328 eligible individuals (mean age, 59.0 ± 10.7 years old; range, 40-94 years). Observation procedures: as part of an ophthalmological and general examination, presence and degree of PEX was assessed using slit-lamp biomicroscopy after medical pupillary dilation. Main outcome measurements: PEX prevalence.ResultsAfter excluding pseudophakic and aphakic individuals, the study included 5,451 (92.4%) participants. PEX prevalence (3.6%; 95% confidence interval [CI]:3.1-4.1), increased from 0.5% (95% CI, 0.1-0.9) in individuals 40 to <50 years old to 10.4% (95% CI, 5.0-15.8) in individuals aged 80+ years. Higher PEX prevalence was associated (multivariate analysis) with older age (odds ratio [OR], 1.09; 95% CI, 1.07-1.11; P < 0.001), Russian ethnicity (OR, 1.50; 95% CI, 2.09-1.11;P = 0.02), higher prevalence of open-angle glaucoma (OR, 2.40; 95% CI, 1.36-4.23;P = 0.003), and higher intraocular pressure (OR, 1.06; 95% CI, 1.02-1.09;P = 0.001). PEX prevalence was not significantly associated with gender (P = 0.49), region of habitation (P = 0.11), body mass index (P = 0.68), level of education (P = 0.26), smoking (P = 0.11), alcohol consumption (P = 0.52), history of cardiovascular or cerebrovascular disease (P = 0.94) and dementia (P = 0.77), prevalence of diabetes mellitus (P = 0.16), arterial hypertension (P = 0.45), chronic obstructive pulmonary disease (P = 0.73), chronic kidney disease (P = 0.09), and hearing loss (P = 0.31).ConclusionsIn this typical, ethnically mixed, population from Russia with an age of 40+ years, PEX prevalence (3.6%; 95% CI, 3.1-4.1) was associated with older age, Russian ethnicity, higher intraocular pressure and open-angle glaucoma. It was independent of any systemic parameter including diabetes, arterial hypertension, previous cardiovascular and cerebrovascular diseases and dementia.
To assess the prevalence of pseudoexfoliation (PEX) and its associations in a Russian population. Population-based cross-sectional study. Setting: Ufa capital of Bashkortostan, Russia and a rural region in Bashkortostan. the Ural Eye and Medical Study included 5,899 (80.5%) of 7,328 eligible individuals (mean age, 59.0 ± 10.7 years old; range, 40-94 years). Observation procedures: as part of an ophthalmological and general examination, presence and degree of PEX was assessed using slit-lamp biomicroscopy after medical pupillary dilation. Main outcome measurements: PEX prevalence. After excluding pseudophakic and aphakic individuals, the study included 5,451 (92.4%) participants. PEX prevalence (3.6%; 95% confidence interval [CI]:3.1-4.1), increased from 0.5% (95% CI, 0.1-0.9) in individuals 40 to <50 years old to 10.4% (95% CI, 5.0-15.8) in individuals aged 80+ years. Higher PEX prevalence was associated (multivariate analysis) with older age (odds ratio [OR], 1.09; 95% CI, 1.07-1.11; P < 0.001), Russian ethnicity (OR, 1.50; 95% CI, 2.09-1.11;P = 0.02), higher prevalence of open-angle glaucoma (OR, 2.40; 95% CI, 1.36-4.23;P = 0.003), and higher intraocular pressure (OR, 1.06; 95% CI, 1.02-1.09;P = 0.001). PEX prevalence was not significantly associated with gender (P = 0.49), region of habitation (P = 0.11), body mass index (P = 0.68), level of education (P = 0.26), smoking (P = 0.11), alcohol consumption (P = 0.52), history of cardiovascular or cerebrovascular disease (P = 0.94) and dementia (P = 0.77), prevalence of diabetes mellitus (P = 0.16), arterial hypertension (P = 0.45), chronic obstructive pulmonary disease (P = 0.73), chronic kidney disease (P = 0.09), and hearing loss (P = 0.31). In this typical, ethnically mixed, population from Russia with an age of 40+ years, PEX prevalence (3.6%; 95% CI, 3.1-4.1) was associated with older age, Russian ethnicity, higher intraocular pressure and open-angle glaucoma. It was independent of any systemic parameter including diabetes, arterial hypertension, previous cardiovascular and cerebrovascular diseases and dementia.
To assess the prevalence of pseudoexfoliation (PEX) and its associations in a Russian population.PURPOSETo assess the prevalence of pseudoexfoliation (PEX) and its associations in a Russian population.Population-based cross-sectional study.DESIGNPopulation-based cross-sectional study.Setting: Ufa capital of Bashkortostan, Russia and a rural region in Bashkortostan.METHODSSetting: Ufa capital of Bashkortostan, Russia and a rural region in Bashkortostan.the Ural Eye and Medical Study included 5,899 (80.5%) of 7,328 eligible individuals (mean age, 59.0 ± 10.7 years old; range, 40-94 years).PARTICIPANTSthe Ural Eye and Medical Study included 5,899 (80.5%) of 7,328 eligible individuals (mean age, 59.0 ± 10.7 years old; range, 40-94 years).as part of an ophthalmological and general examination, presence and degree of PEX was assessed using slit-lamp biomicroscopy after medical pupillary dilation.OBSERVATION PROCEDURESas part of an ophthalmological and general examination, presence and degree of PEX was assessed using slit-lamp biomicroscopy after medical pupillary dilation.PEX prevalence.MAIN OUTCOME MEASUREMENTSPEX prevalence.After excluding pseudophakic and aphakic individuals, the study included 5,451 (92.4%) participants. PEX prevalence (3.6%; 95% confidence interval [CI]:3.1-4.1), increased from 0.5% (95% CI, 0.1-0.9) in individuals 40 to <50 years old to 10.4% (95% CI, 5.0-15.8) in individuals aged 80+ years. Higher PEX prevalence was associated (multivariate analysis) with older age (odds ratio [OR], 1.09; 95% CI, 1.07-1.11; P < 0.001), Russian ethnicity (OR, 1.50; 95% CI, 2.09-1.11;P = 0.02), higher prevalence of open-angle glaucoma (OR, 2.40; 95% CI, 1.36-4.23;P = 0.003), and higher intraocular pressure (OR, 1.06; 95% CI, 1.02-1.09;P = 0.001). PEX prevalence was not significantly associated with gender (P = 0.49), region of habitation (P = 0.11), body mass index (P = 0.68), level of education (P = 0.26), smoking (P = 0.11), alcohol consumption (P = 0.52), history of cardiovascular or cerebrovascular disease (P = 0.94) and dementia (P = 0.77), prevalence of diabetes mellitus (P = 0.16), arterial hypertension (P = 0.45), chronic obstructive pulmonary disease (P = 0.73), chronic kidney disease (P = 0.09), and hearing loss (P = 0.31).RESULTSAfter excluding pseudophakic and aphakic individuals, the study included 5,451 (92.4%) participants. PEX prevalence (3.6%; 95% confidence interval [CI]:3.1-4.1), increased from 0.5% (95% CI, 0.1-0.9) in individuals 40 to <50 years old to 10.4% (95% CI, 5.0-15.8) in individuals aged 80+ years. Higher PEX prevalence was associated (multivariate analysis) with older age (odds ratio [OR], 1.09; 95% CI, 1.07-1.11; P < 0.001), Russian ethnicity (OR, 1.50; 95% CI, 2.09-1.11;P = 0.02), higher prevalence of open-angle glaucoma (OR, 2.40; 95% CI, 1.36-4.23;P = 0.003), and higher intraocular pressure (OR, 1.06; 95% CI, 1.02-1.09;P = 0.001). PEX prevalence was not significantly associated with gender (P = 0.49), region of habitation (P = 0.11), body mass index (P = 0.68), level of education (P = 0.26), smoking (P = 0.11), alcohol consumption (P = 0.52), history of cardiovascular or cerebrovascular disease (P = 0.94) and dementia (P = 0.77), prevalence of diabetes mellitus (P = 0.16), arterial hypertension (P = 0.45), chronic obstructive pulmonary disease (P = 0.73), chronic kidney disease (P = 0.09), and hearing loss (P = 0.31).In this typical, ethnically mixed, population from Russia with an age of 40+ years, PEX prevalence (3.6%; 95% CI, 3.1-4.1) was associated with older age, Russian ethnicity, higher intraocular pressure and open-angle glaucoma. It was independent of any systemic parameter including diabetes, arterial hypertension, previous cardiovascular and cerebrovascular diseases and dementia.CONCLUSIONSIn this typical, ethnically mixed, population from Russia with an age of 40+ years, PEX prevalence (3.6%; 95% CI, 3.1-4.1) was associated with older age, Russian ethnicity, higher intraocular pressure and open-angle glaucoma. It was independent of any systemic parameter including diabetes, arterial hypertension, previous cardiovascular and cerebrovascular diseases and dementia.
To assess the prevalence of pseudoexfoliation (PEX) and its associations in a Russian population. Population-based cross-sectional study. Setting: Ufa capital of Bashkortostan, Russia and a rural region in Bashkortostan. the Ural Eye and Medical Study included 5,899 (80.5%) of 7,328 eligible individuals (mean age, 59.0 ± 10.7 years old; range, 40-94 years). as part of an ophthalmological and general examination, presence and degree of PEX was assessed using slit-lamp biomicroscopy after medical pupillary dilation. PEX prevalence. After excluding pseudophakic and aphakic individuals, the study included 5,451 (92.4%) participants. PEX prevalence (3.6%; 95% confidence interval [CI]:3.1-4.1), increased from 0.5% (95% CI, 0.1-0.9) in individuals 40 to <50 years old to 10.4% (95% CI, 5.0-15.8) in individuals aged 80+ years. Higher PEX prevalence was associated (multivariate analysis) with older age (odds ratio [OR], 1.09; 95% CI, 1.07-1.11; P < 0.001), Russian ethnicity (OR, 1.50; 95% CI, 2.09-1.11;P = 0.02), higher prevalence of open-angle glaucoma (OR, 2.40; 95% CI, 1.36-4.23;P = 0.003), and higher intraocular pressure (OR, 1.06; 95% CI, 1.02-1.09;P = 0.001). PEX prevalence was not significantly associated with gender (P = 0.49), region of habitation (P = 0.11), body mass index (P = 0.68), level of education (P = 0.26), smoking (P = 0.11), alcohol consumption (P = 0.52), history of cardiovascular or cerebrovascular disease (P = 0.94) and dementia (P = 0.77), prevalence of diabetes mellitus (P = 0.16), arterial hypertension (P = 0.45), chronic obstructive pulmonary disease (P = 0.73), chronic kidney disease (P = 0.09), and hearing loss (P = 0.31). In this typical, ethnically mixed, population from Russia with an age of 40+ years, PEX prevalence (3.6%; 95% CI, 3.1-4.1) was associated with older age, Russian ethnicity, higher intraocular pressure and open-angle glaucoma. It was independent of any systemic parameter including diabetes, arterial hypertension, previous cardiovascular and cerebrovascular diseases and dementia.
Author Bikbova, Guzel M.
Arslangareeva, Inga I.
Nikitin, Nikolay A.
Uzianbaeva, Yulia V.
Rusakova, Iulia A.
Jonas, Jost B.
Bikbov, Mukharram M.
Yakupova, Dilya F.
Panda-Jonas, Songhomitra
Zaynetdinov, Artur F.
Salavatova, Venera F.
Kazakbaeva, Gyulli M.
Gilmanshin, Timur R.
Khalimov, Timur A.
Nuriev, Ildar F.
Rakhimova, Ellina M.
Zainullin, Rinat M.
Author_xml – sequence: 1
  givenname: Mukharram M.
  surname: Bikbov
  fullname: Bikbov, Mukharram M.
  email: Bikbov.m@gmail.com
  organization: Ufa Eye Research Institute, Ufa, Bashkortostan, Russia
– sequence: 2
  givenname: Rinat M.
  surname: Zainullin
  fullname: Zainullin, Rinat M.
  organization: Ufa Eye Research Institute, Ufa, Bashkortostan, Russia
– sequence: 3
  givenname: Timur R.
  surname: Gilmanshin
  fullname: Gilmanshin, Timur R.
  organization: Ufa Eye Research Institute, Ufa, Bashkortostan, Russia
– sequence: 4
  givenname: Gyulli M.
  surname: Kazakbaeva
  fullname: Kazakbaeva, Gyulli M.
  organization: Ufa Eye Research Institute, Ufa, Bashkortostan, Russia
– sequence: 5
  givenname: Dilya F.
  surname: Yakupova
  fullname: Yakupova, Dilya F.
  organization: Ufa Eye Research Institute, Ufa, Bashkortostan, Russia
– sequence: 6
  givenname: Ildar F.
  surname: Nuriev
  fullname: Nuriev, Ildar F.
  organization: Ufa Eye Research Institute, Ufa, Bashkortostan, Russia
– sequence: 7
  givenname: Artur F.
  surname: Zaynetdinov
  fullname: Zaynetdinov, Artur F.
  organization: Ufa Eye Research Institute, Ufa, Bashkortostan, Russia
– sequence: 8
  givenname: Timur A.
  surname: Khalimov
  fullname: Khalimov, Timur A.
  organization: Ufa Eye Research Institute, Ufa, Bashkortostan, Russia
– sequence: 9
  givenname: Songhomitra
  surname: Panda-Jonas
  fullname: Panda-Jonas, Songhomitra
  organization: Department of Ophthalmology, Medical Faculty Mannheim of the Ruprecht-Karls-University of Heidelberg, Mannheim, Germany
– sequence: 10
  givenname: Yulia V.
  surname: Uzianbaeva
  fullname: Uzianbaeva, Yulia V.
  organization: Ufa Eye Research Institute, Ufa, Bashkortostan, Russia
– sequence: 11
  givenname: Ellina M.
  surname: Rakhimova
  fullname: Rakhimova, Ellina M.
  organization: Ufa Eye Research Institute, Ufa, Bashkortostan, Russia
– sequence: 12
  givenname: Iulia A.
  surname: Rusakova
  fullname: Rusakova, Iulia A.
  organization: Ufa Eye Research Institute, Ufa, Bashkortostan, Russia
– sequence: 13
  givenname: Venera F.
  surname: Salavatova
  fullname: Salavatova, Venera F.
  organization: Ufa Eye Research Institute, Ufa, Bashkortostan, Russia
– sequence: 14
  givenname: Inga I.
  surname: Arslangareeva
  fullname: Arslangareeva, Inga I.
  organization: Ufa Eye Research Institute, Ufa, Bashkortostan, Russia
– sequence: 15
  givenname: Guzel M.
  surname: Bikbova
  fullname: Bikbova, Guzel M.
  organization: Ufa Eye Research Institute, Ufa, Bashkortostan, Russia
– sequence: 16
  givenname: Nikolay A.
  surname: Nikitin
  fullname: Nikitin, Nikolay A.
  organization: Ufa Eye Research Institute, Ufa, Bashkortostan, Russia
– sequence: 17
  givenname: Jost B.
  surname: Jonas
  fullname: Jonas, Jost B.
  email: Jost.Jonas@medma.uni-heidelberg.de
  organization: Department of Ophthalmology, Medical Faculty Mannheim of the Ruprecht-Karls-University of Heidelberg, Mannheim, Germany
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31606443$$D View this record in MEDLINE/PubMed
BookMark eNqFkcFPHCEUxkljU1frH9BLQ9KLl9kCw8ws7ckYbU00bqqeCQuPlCkLW5gx3f--jGs97MGe4L33-17g-47QQYgBEPpAyZwS2n7u56qPc0aoKPWckPoNmtFFJyq6EPQAzQghrBK14IfoKOe-lG3Hu3fosKYtaTmvZygsEzwqD0EDVsHgs5yjdmoAgy-VHmLKOFq8zDCaCH9s9GXmYsAuYIV_jDk7FfAybkb_1P-C738CfkjK44vtbuMNGKdLfTeMZvsevbXKZzh5Po_Rw-XF_fn36vr229X52XWlueiGqmlWlinQ2nK7MoZxEKQ1emEtFXxFFTS01aqZxhrK_2yja11ujWpERyyrj9Hpbu8mxd8j5EGuXdbgvQoQxyxZTRre1Q2tC_ppD-3jmEJ5XaH4grWCsYn6-EyNqzUYuUlurdJW_nOyAHQH6BRzTmBfEErklJbsZUlLTmlNrZJW0XR7Gu2GJx-HpJx_Vfl1p4Ri4qODJLN2U4jGJdCDNNG9qhZ7au1dmFL6Bdv_aP8Cg9jCPQ
CitedBy_id crossref_primary_10_1038_s41598_020_75313_0
crossref_primary_10_4103_IJO_IJO_3365_22
crossref_primary_10_1038_s41433_025_03615_6
crossref_primary_10_1007_s00417_021_05241_w
crossref_primary_10_1038_s41433_022_02026_1
crossref_primary_10_1080_09286586_2023_2291787
crossref_primary_10_7759_cureus_38631
crossref_primary_10_1038_s41598_020_77344_z
crossref_primary_10_3390_metabo15070469
crossref_primary_10_1111_echo_15031
crossref_primary_10_4103_IJO_IJO_2619_22
crossref_primary_10_1016_j_survophthal_2022_09_001
crossref_primary_10_1016_j_ajo_2024_06_015
crossref_primary_10_1016_j_ophtha_2021_11_001
crossref_primary_10_1097_IJG_0000000000001784
crossref_primary_10_1097_j_jcrs_0000000000000885
crossref_primary_10_2147_OPTO_S321716
crossref_primary_10_1016_j_mam_2023_101214
crossref_primary_10_1016_j_ophtha_2023_07_014
crossref_primary_10_4103_meajo_MEAJO_358_20
crossref_primary_10_1038_s41433_021_01846_x
crossref_primary_10_1167_iovs_63_9_15
Cites_doi 10.1111/crj.12903
10.1097/IJG.0b013e3181d9d8bd
10.1034/j.1600-0420.2001.790314.x
10.1016/S0002-9394(99)00466-3
10.1016/S0140-6736(16)30388-9
10.1001/archopht.1987.01060080078032
10.1167/iovs.04-1062
10.1016/S0002-9394(00)00732-7
10.1007/s11886-016-0738-5
10.1016/S0002-9394(02)02271-7
10.1016/j.ebiom.2015.05.024
10.1016/j.ajo.2019.05.005
10.1167/iovs.14-13991
10.1111/aos.12184
10.1016/j.ophtha.2015.02.007
10.1371/journal.pone.0076770
10.1097/IJG.0b013e3181ca76c4
10.1136/bjo.2004.047605
10.1001/archopht.1992.01080240092038
10.1016/S0002-9394(14)70908-0
10.1111/aos.13882
10.1016/S0039-6257(00)00196-X
10.1016/j.ajo.2009.03.024
10.1111/j.1600-0420.2007.01051.x
10.1136/bjophthalmol-2012-301906
10.1371/journal.pone.0211186
10.1016/j.ophtha.2013.01.020
10.1111/j.1442-9071.2011.02696.x
10.1126/science.1146554
10.1136/bjo.2008.141523
10.1016/j.ajo.2019.02.030
10.1371/journal.pone.0215636
10.1111/aos.12402
10.1097/00061198-199400320-00018
10.1016/j.ophtha.2015.05.031
10.1161/HYP.0000000000000066
10.1136/bjo.86.2.238
10.1001/archophthalmol.2011.191
10.1097/01.ijg.0000185436.15675.b3
10.1016/j.ophtha.2012.10.036
ContentType Journal Article
Copyright 2019 Elsevier Inc.
Copyright © 2019 Elsevier Inc. All rights reserved.
2019. Elsevier Inc.
Copyright_xml – notice: 2019 Elsevier Inc.
– notice: Copyright © 2019 Elsevier Inc. All rights reserved.
– notice: 2019. Elsevier Inc.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
NAPCQ
7X8
DOI 10.1016/j.ajo.2019.10.003
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)


MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1879-1891
EndPage 166
ExternalDocumentID 31606443
10_1016_j_ajo_2019_10_003
S0002939419304921
Genre Journal Article
GeographicLocations Russia
GeographicLocations_xml – name: Russia
GroupedDBID ---
--K
--M
-~X
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1CY
1P~
1~.
1~5
23M
4.4
457
4G.
53G
5GY
5RE
5VS
6J9
7-5
71M
8P~
AABNK
AAEDT
AAEDW
AAHTB
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQQT
AAQXK
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABCQX
ABDPE
ABFNM
ABFRF
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABPEJ
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACLOT
ACNCT
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
ADMUD
ADNMO
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGHFR
AGQPQ
AGUBO
AGYEJ
AHMBA
AI.
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKEYQ
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
CS3
EBS
EFJIC
EFKBS
EFLBG
EJD
EMOBN
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
M41
MO0
N4W
N9A
O-L
O9-
OAUVE
OF-
OPF
OQ~
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
R2-
ROL
RPZ
SCC
SDF
SDG
SDP
SEL
SES
SPCBC
SSH
SSZ
SV3
T5K
UNMZH
UV1
VH1
WH7
WOW
X7M
XPP
Z5R
ZGI
ZXP
~G-
~HD
3V.
7RV
7X7
8FI
AACTN
AAIAV
ABLVK
ABYKQ
AFCTW
AFKRA
AFKWA
AHPSJ
AJBFU
AJOXV
AMFUW
AZQEC
BENPR
FYUFA
G8K
GUQSH
LCYCR
M1P
M2O
RIG
ZA5
9DU
AAYXX
CITATION
AGCQF
AGRNS
CGR
CUY
CVF
ECM
EIF
NPM
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-c497t-55bf2aeccf4fbdd24e906dc8ff194b1ae516ca5cf4fce394f5c3cce35a5970f23
ISICitedReferencesCount 27
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000512216200019&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0002-9394
1879-1891
IngestDate Sun Sep 28 02:24:39 EDT 2025
Mon Oct 06 18:39:04 EDT 2025
Mon Jul 21 06:02:51 EDT 2025
Tue Nov 18 21:00:25 EST 2025
Sat Nov 29 06:58:24 EST 2025
Fri Feb 23 02:50:30 EST 2024
Tue Oct 14 19:30:39 EDT 2025
IsPeerReviewed true
IsScholarly true
Language English
License Copyright © 2019 Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c497t-55bf2aeccf4fbdd24e906dc8ff194b1ae516ca5cf4fce394f5c3cce35a5970f23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 31606443
PQID 2348269223
PQPubID 41749
PageCount 9
ParticipantIDs proquest_miscellaneous_2305473513
proquest_journals_2348269223
pubmed_primary_31606443
crossref_primary_10_1016_j_ajo_2019_10_003
crossref_citationtrail_10_1016_j_ajo_2019_10_003
elsevier_sciencedirect_doi_10_1016_j_ajo_2019_10_003
elsevier_clinicalkey_doi_10_1016_j_ajo_2019_10_003
PublicationCentury 2000
PublicationDate February 2020
2020-02-00
20200201
PublicationDateYYYYMMDD 2020-02-01
PublicationDate_xml – month: 02
  year: 2020
  text: February 2020
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Chicago
PublicationTitle American journal of ophthalmology
PublicationTitleAlternate Am J Ophthalmol
PublicationYear 2020
Publisher Elsevier Inc
Elsevier Limited
Publisher_xml – name: Elsevier Inc
– name: Elsevier Limited
References Schlötzer-Schrehardt, Koca, Naumann, Volkholz (bib4) 1992; 110
Topouzis, Founti, Yu, Wilson, Coleman (bib32) 2019
Svensson, Ekström (bib40) 2015; 93
Stevens, Alkema, Black (bib22) 2016; 388
Yan, Wang, Xu, Xu, Wei, Jonas (bib26) 2015; 122
Ferris, Wilkinson, Bird (bib27) 2013; 120
Thorleifsson, Magnusson, Sulem (bib2) 2007; 317
Bikbov, Fayzrakhmanov, Kazakbaeva (bib21) 2019; 14
Vijaya, Asokan, Panday (bib31) 2015; 122
Krumbiegel, Pasutto, Mardin (bib37) 2010; 19
Slettedal, Sandvik, Ringvold (bib39) 2015; 2
Bikbov, Kazakbaeva, Zainullin (bib19) 2019; 204
Ritch (bib7) 1994; 3
Thomas, Nirmalan, Krishnaiah (bib11) 2005; 46
Bikbov, Kazakbaeva, Gilmanshin (bib18) 2019; 14
Prince, Streeten, Ritch, Dark, Sperling (bib24) 1987; 105
Landers, Henderson, Craig (bib29) 2012; 40
Jonas, Nangia, Matin (bib17) 2013; 8
Topouzis, Harris, Wilson (bib33) 2009; 148
(bib25) 2001; 131
Foster, Seah (bib10) 2005; 89
Arnarsson, Damji, Sverrisson, Sasaki, Jonasson (bib13) 2007; 85
Xu, You, Wang, Jonas (bib34) 2013; 97
Siordia, Franco, Golden, Dar (bib6) 2016; 18
Batur, Seven, Tanrıkulu, Ekin, Tekin, Yasar (bib38) 2018; 12
Ekström, Kilander (bib35) 2014; 92
bib20
Linnér, Popovic, Gottfries, Jonsson, Sjögren, Wallin (bib36) 2001; 79
Ekström, Wilger, Wanhainen (bib41) 2019; 97
Anastasopoulos, Coleman, Wilson (bib3) 2014; 55
Abdul-Rahman, Casson, Newland (bib14) 2008; 92
Miyazaki, Kubota, Kubo (bib12) 2005; 14
McCarty, Taylor (bib8) 2000; 129
Krishnadas, Nirmalan, Ramakrishnan (bib9) 2003; 135
Foster, Buhrmann, Quigley, Johnson (bib28) 2002; 86
Ritch, Schlötzer-Schrehardt (bib1) 2001; 45
Mitchell, Wang, Smith (bib5) 1997; 124
You, Xu, Wang (bib16) 2013; 120
Whelton, Carey, Aronow (bib23) 2018; 71
Stein, Pasquale, Talwar (bib30) 2011; 129
Anastasopoulos, Topouzis, Wilson (bib15) 2011; 20
Linnér (10.1016/j.ajo.2019.10.003_bib36) 2001; 79
Yan (10.1016/j.ajo.2019.10.003_bib26) 2015; 122
Topouzis (10.1016/j.ajo.2019.10.003_bib32) 2019
Krumbiegel (10.1016/j.ajo.2019.10.003_bib37) 2010; 19
Foster (10.1016/j.ajo.2019.10.003_bib28) 2002; 86
Xu (10.1016/j.ajo.2019.10.003_bib34) 2013; 97
Slettedal (10.1016/j.ajo.2019.10.003_bib39) 2015; 2
Anastasopoulos (10.1016/j.ajo.2019.10.003_bib3) 2014; 55
Vijaya (10.1016/j.ajo.2019.10.003_bib31) 2015; 122
Anastasopoulos (10.1016/j.ajo.2019.10.003_bib15) 2011; 20
Jonas (10.1016/j.ajo.2019.10.003_bib17) 2013; 8
Batur (10.1016/j.ajo.2019.10.003_bib38) 2018; 12
Ritch (10.1016/j.ajo.2019.10.003_bib1) 2001; 45
Mitchell (10.1016/j.ajo.2019.10.003_bib5) 1997; 124
Stein (10.1016/j.ajo.2019.10.003_bib30) 2011; 129
Abdul-Rahman (10.1016/j.ajo.2019.10.003_bib14) 2008; 92
Stevens (10.1016/j.ajo.2019.10.003_bib22) 2016; 388
Topouzis (10.1016/j.ajo.2019.10.003_bib33) 2009; 148
Ferris (10.1016/j.ajo.2019.10.003_bib27) 2013; 120
Krishnadas (10.1016/j.ajo.2019.10.003_bib9) 2003; 135
McCarty (10.1016/j.ajo.2019.10.003_bib8) 2000; 129
Miyazaki (10.1016/j.ajo.2019.10.003_bib12) 2005; 14
Bikbov (10.1016/j.ajo.2019.10.003_bib19) 2019; 204
Whelton (10.1016/j.ajo.2019.10.003_bib23) 2018; 71
Arnarsson (10.1016/j.ajo.2019.10.003_bib13) 2007; 85
Siordia (10.1016/j.ajo.2019.10.003_bib6) 2016; 18
Thomas (10.1016/j.ajo.2019.10.003_bib11) 2005; 46
Bikbov (10.1016/j.ajo.2019.10.003_bib21) 2019; 14
Prince (10.1016/j.ajo.2019.10.003_bib24) 1987; 105
Ekström (10.1016/j.ajo.2019.10.003_bib35) 2014; 92
Svensson (10.1016/j.ajo.2019.10.003_bib40) 2015; 93
Ekström (10.1016/j.ajo.2019.10.003_bib41) 2019; 97
Bikbov (10.1016/j.ajo.2019.10.003_bib18) 2019; 14
(10.1016/j.ajo.2019.10.003_bib25) 2001; 131
Schlötzer-Schrehardt (10.1016/j.ajo.2019.10.003_bib4) 1992; 110
You (10.1016/j.ajo.2019.10.003_bib16) 2013; 120
Ritch (10.1016/j.ajo.2019.10.003_bib7) 1994; 3
Foster (10.1016/j.ajo.2019.10.003_bib10) 2005; 89
Landers (10.1016/j.ajo.2019.10.003_bib29) 2012; 40
Thorleifsson (10.1016/j.ajo.2019.10.003_bib2) 2007; 317
References_xml – volume: 19
  start-page: 561
  year: 2010
  end-page: 565
  ident: bib37
  article-title: Apolipoprotein E genotypes in pseudoexfoliation syndrome and pseudoexfoliation glaucoma
  publication-title: J Glaucoma
– volume: 120
  start-page: 844
  year: 2013
  end-page: 851
  ident: bib27
  article-title: Clinical classification of age-related macular degeneration
  publication-title: Ophthalmology
– volume: 122
  start-page: 1158
  year: 2015
  end-page: 1164
  ident: bib31
  article-title: Six-year incidence and baseline risk factors for pseudoexfoliation in a South Indian population: the Chennai Eye Disease Incidence Study
  publication-title: Ophthalmology
– volume: 97
  start-page: 1215
  year: 2013
  ident: bib34
  article-title: Cognitive function and pseudoexfoliation syndrome. The Beijing Eye Study 2011
  publication-title: Br J Ophthalmol
– volume: 317
  start-page: 1397
  year: 2007
  end-page: 1400
  ident: bib2
  article-title: Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma
  publication-title: Science
– volume: 120
  start-page: 1551
  year: 2013
  end-page: 1558
  ident: bib16
  article-title: Pseudoexfoliation: normative data and associations. The Beijing Eye Study 2011
  publication-title: Ophthalmology
– volume: 86
  start-page: 238
  year: 2002
  end-page: 242
  ident: bib28
  article-title: The definition and classification of glaucoma in prevalence surveys
  publication-title: Br J Ophthalmol
– year: 2019
  ident: bib32
  article-title: Twelve-year incidence and baseline risk factors for pseudoexfoliation: the Thessaloniki Eye Study (An American Ophthalmological Society Thesis)
  publication-title: Am J Ophthalmol
– volume: 20
  start-page: 160
  year: 2011
  end-page: 166
  ident: bib15
  article-title: Characteristics of pseudoexfoliation in the Thessaloniki Eye Study
  publication-title: J Glaucoma
– volume: 18
  start-page: 61
  year: 2016
  ident: bib6
  article-title: Ocular pseudoexfoliation syndrome linkage to cardiovascular disease
  publication-title: Curr Cardiol Rep
– volume: 55
  start-page: 4238
  year: 2014
  end-page: 4243
  ident: bib3
  article-title: Association of LOXL1 polymorphisms with pseudoexfoliation, glaucoma, intraocular pressure, and systemic diseases in a Greek population. The Thessaloniki eye study
  publication-title: Invest Ophthalmol Vis Sci
– volume: 93
  start-page: 162
  year: 2015
  end-page: 164
  ident: bib40
  article-title: Pseudoexfoliation and mortality: a population-based 30-year follow-up study
  publication-title: Acta Ophthalmol
– volume: 92
  start-page: 355
  year: 2014
  end-page: 358
  ident: bib35
  article-title: Pseudoexfoliation and Alzheimer's disease: a population-based 30-year follow-up study
  publication-title: Acta Ophthalmol
– volume: 14
  start-page: e0215636
  year: 2019
  ident: bib21
  article-title: Prevalence, awareness and control of diabetes in Russia: the Ural Eye and Medical Study on adults aged 40+ years
  publication-title: PLoS One
– volume: 3
  start-page: 176
  year: 1994
  end-page: 178
  ident: bib7
  article-title: Exfoliation syndrome–the most common identifiable cause of open-angle glaucoma
  publication-title: J Glaucoma
– volume: 71
  start-page: 1269
  year: 2018
  end-page: 1324
  ident: bib23
  article-title: 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines
  publication-title: Hypertension
– volume: 12
  start-page: 2271
  year: 2018
  end-page: 2276
  ident: bib38
  article-title: Pulmonary functions in pseudoexfoliation syndrome
  publication-title: Clin Respir J
– volume: 85
  start-page: 822
  year: 2007
  end-page: 827
  ident: bib13
  article-title: Pseudoexfoliation in the Reykjavik Eye Study: prevalence and related ophthalmological variables
  publication-title: Acta Ophthalmol Scand
– volume: 122
  start-page: 1873
  year: 2015
  end-page: 1880
  ident: bib26
  article-title: Fundus tessellation: prevalence and associated factors. The Beijing Eye Study 2011
  publication-title: Ophthalmology
– volume: 129
  start-page: 1053
  year: 2011
  end-page: 1060
  ident: bib30
  article-title: Geographic and climatic factors associated with exfoliation syndrome
  publication-title: Arch Ophthalmol
– volume: 97
  start-page: 80
  year: 2019
  end-page: 83
  ident: bib41
  article-title: Pseudoexfoliation and aortic aneurysm: a long-term follow-up study
  publication-title: Acta Ophthalmol
– volume: 92
  start-page: 1325
  year: 2008
  end-page: 1328
  ident: bib14
  article-title: Pseudoexfoliation in a rural Burmese population: the Meiktila Eye Study
  publication-title: Br J Ophthalmol
– volume: 124
  start-page: 685
  year: 1997
  end-page: 687
  ident: bib5
  article-title: Association of pseudoexfoliation syndrome with increased vascular risk
  publication-title: Am J Ophthalmol
– volume: 89
  start-page: 239
  year: 2005
  end-page: 240
  ident: bib10
  article-title: The prevalence of pseudoexfoliation syndrome in Chinese people: the Tanjong Pagar Survey
  publication-title: Br J Ophthalmol
– volume: 388
  start-page: e19
  year: 2016
  end-page: e23
  ident: bib22
  article-title: Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement
  publication-title: Lancet
– volume: 129
  start-page: 629
  year: 2000
  end-page: 633
  ident: bib8
  article-title: Pseudoexfoliation syndrome in Australian adults
  publication-title: Am J Ophthalmol
– volume: 46
  start-page: 1170
  year: 2005
  end-page: 1176
  ident: bib11
  article-title: Pseudoexfoliation in southern India: the Andhra Pradesh Eye Disease Study
  publication-title: Invest Ophthalmol Vis Sci
– volume: 14
  start-page: e0211186
  year: 2019
  ident: bib18
  article-title: Axial length and its associations in a Russian population: the Ural Eye and Medical Study
  publication-title: PLoS One
– volume: 14
  start-page: 482
  year: 2005
  end-page: 484
  ident: bib12
  article-title: The prevalence of pseudoexfoliation syndrome in a Japanese population: the Hisayama study
  publication-title: J Glaucoma
– volume: 79
  start-page: 283
  year: 2001
  end-page: 285
  ident: bib36
  article-title: The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer's type
  publication-title: Acta Ophthalmol Scand
– volume: 148
  start-page: 606
  year: 2009
  end-page: 613
  ident: bib33
  article-title: Increased likelihood of glaucoma at the same screening intraocular pressure in subjects with pseudoexfoliation: the Thessaloniki Eye Study
  publication-title: Am J Ophthalmol
– volume: 135
  start-page: 830
  year: 2003
  end-page: 837
  ident: bib9
  article-title: Pseudoexfoliation in a rural population of southern India: the Aravind Comprehensive Eye Survey
  publication-title: Am J Ophthalmol
– volume: 131
  start-page: 167
  year: 2001
  end-page: 175
  ident: bib25
  article-title: The Age-Related Eye Disease Study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4
  publication-title: Am J Ophthalmol
– volume: 45
  start-page: 265
  year: 2001
  end-page: 315
  ident: bib1
  article-title: Exfoliation syndrome
  publication-title: Surv Ophthalmol
– volume: 110
  start-page: 1752
  year: 1992
  end-page: 1756
  ident: bib4
  article-title: Pseudoexfoliation syndrome: ocular manifestation of a systemic disorder?
  publication-title: Arch Ophthalmol
– volume: 105
  start-page: 1076
  year: 1987
  end-page: 1082
  ident: bib24
  article-title: Preclinical diagnosis of pseudoexfoliative syndrome
  publication-title: Arch Ophthalmol
– ident: bib20
  article-title: Demographics of Russia
– volume: 2
  start-page: 765
  year: 2015
  end-page: 769
  ident: bib39
  article-title: Ocular pseudoexfoliation syndrome and life span
  publication-title: EBioMedicine
– volume: 8
  start-page: e76770
  year: 2013
  ident: bib17
  article-title: Pseudoexfoliation: normative data and associations. The Central India Eye and Medical Study
  publication-title: PLoS One
– volume: 204
  start-page: 130
  year: 2019
  end-page: 139
  ident: bib19
  article-title: Intraocular pressure and its associations in a Russian population: the Ural Eye and Medical Study
  publication-title: Am J Ophthalmol
– volume: 40
  start-page: 454
  year: 2012
  end-page: 457
  ident: bib29
  article-title: Prevalence of pseudoexfoliation syndrome in indigenous Australians within central Australia: the Central Australian Ocular Health Study
  publication-title: Clin Experiment Ophthalmol
– volume: 12
  start-page: 2271
  year: 2018
  ident: 10.1016/j.ajo.2019.10.003_bib38
  article-title: Pulmonary functions in pseudoexfoliation syndrome
  publication-title: Clin Respir J
  doi: 10.1111/crj.12903
– volume: 20
  start-page: 160
  year: 2011
  ident: 10.1016/j.ajo.2019.10.003_bib15
  article-title: Characteristics of pseudoexfoliation in the Thessaloniki Eye Study
  publication-title: J Glaucoma
  doi: 10.1097/IJG.0b013e3181d9d8bd
– volume: 79
  start-page: 283
  year: 2001
  ident: 10.1016/j.ajo.2019.10.003_bib36
  article-title: The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer's type
  publication-title: Acta Ophthalmol Scand
  doi: 10.1034/j.1600-0420.2001.790314.x
– volume: 129
  start-page: 629
  year: 2000
  ident: 10.1016/j.ajo.2019.10.003_bib8
  article-title: Pseudoexfoliation syndrome in Australian adults
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(99)00466-3
– volume: 388
  start-page: e19
  year: 2016
  ident: 10.1016/j.ajo.2019.10.003_bib22
  article-title: Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)30388-9
– volume: 105
  start-page: 1076
  year: 1987
  ident: 10.1016/j.ajo.2019.10.003_bib24
  article-title: Preclinical diagnosis of pseudoexfoliative syndrome
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1987.01060080078032
– volume: 46
  start-page: 1170
  year: 2005
  ident: 10.1016/j.ajo.2019.10.003_bib11
  article-title: Pseudoexfoliation in southern India: the Andhra Pradesh Eye Disease Study
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.04-1062
– volume: 131
  start-page: 167
  year: 2001
  ident: 10.1016/j.ajo.2019.10.003_bib25
  article-title: The Age-Related Eye Disease Study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(00)00732-7
– volume: 18
  start-page: 61
  year: 2016
  ident: 10.1016/j.ajo.2019.10.003_bib6
  article-title: Ocular pseudoexfoliation syndrome linkage to cardiovascular disease
  publication-title: Curr Cardiol Rep
  doi: 10.1007/s11886-016-0738-5
– volume: 135
  start-page: 830
  year: 2003
  ident: 10.1016/j.ajo.2019.10.003_bib9
  article-title: Pseudoexfoliation in a rural population of southern India: the Aravind Comprehensive Eye Survey
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(02)02271-7
– volume: 2
  start-page: 765
  year: 2015
  ident: 10.1016/j.ajo.2019.10.003_bib39
  article-title: Ocular pseudoexfoliation syndrome and life span
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2015.05.024
– year: 2019
  ident: 10.1016/j.ajo.2019.10.003_bib32
  article-title: Twelve-year incidence and baseline risk factors for pseudoexfoliation: the Thessaloniki Eye Study (An American Ophthalmological Society Thesis)
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2019.05.005
– volume: 55
  start-page: 4238
  year: 2014
  ident: 10.1016/j.ajo.2019.10.003_bib3
  article-title: Association of LOXL1 polymorphisms with pseudoexfoliation, glaucoma, intraocular pressure, and systemic diseases in a Greek population. The Thessaloniki eye study
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.14-13991
– volume: 92
  start-page: 355
  year: 2014
  ident: 10.1016/j.ajo.2019.10.003_bib35
  article-title: Pseudoexfoliation and Alzheimer's disease: a population-based 30-year follow-up study
  publication-title: Acta Ophthalmol
  doi: 10.1111/aos.12184
– volume: 122
  start-page: 1158
  year: 2015
  ident: 10.1016/j.ajo.2019.10.003_bib31
  article-title: Six-year incidence and baseline risk factors for pseudoexfoliation in a South Indian population: the Chennai Eye Disease Incidence Study
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2015.02.007
– volume: 8
  start-page: e76770
  year: 2013
  ident: 10.1016/j.ajo.2019.10.003_bib17
  article-title: Pseudoexfoliation: normative data and associations. The Central India Eye and Medical Study
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0076770
– volume: 19
  start-page: 561
  year: 2010
  ident: 10.1016/j.ajo.2019.10.003_bib37
  article-title: Apolipoprotein E genotypes in pseudoexfoliation syndrome and pseudoexfoliation glaucoma
  publication-title: J Glaucoma
  doi: 10.1097/IJG.0b013e3181ca76c4
– volume: 89
  start-page: 239
  year: 2005
  ident: 10.1016/j.ajo.2019.10.003_bib10
  article-title: The prevalence of pseudoexfoliation syndrome in Chinese people: the Tanjong Pagar Survey
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.2004.047605
– volume: 110
  start-page: 1752
  year: 1992
  ident: 10.1016/j.ajo.2019.10.003_bib4
  article-title: Pseudoexfoliation syndrome: ocular manifestation of a systemic disorder?
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1992.01080240092038
– volume: 124
  start-page: 685
  year: 1997
  ident: 10.1016/j.ajo.2019.10.003_bib5
  article-title: Association of pseudoexfoliation syndrome with increased vascular risk
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(14)70908-0
– volume: 97
  start-page: 80
  year: 2019
  ident: 10.1016/j.ajo.2019.10.003_bib41
  article-title: Pseudoexfoliation and aortic aneurysm: a long-term follow-up study
  publication-title: Acta Ophthalmol
  doi: 10.1111/aos.13882
– volume: 45
  start-page: 265
  year: 2001
  ident: 10.1016/j.ajo.2019.10.003_bib1
  article-title: Exfoliation syndrome
  publication-title: Surv Ophthalmol
  doi: 10.1016/S0039-6257(00)00196-X
– volume: 148
  start-page: 606
  year: 2009
  ident: 10.1016/j.ajo.2019.10.003_bib33
  article-title: Increased likelihood of glaucoma at the same screening intraocular pressure in subjects with pseudoexfoliation: the Thessaloniki Eye Study
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2009.03.024
– volume: 85
  start-page: 822
  year: 2007
  ident: 10.1016/j.ajo.2019.10.003_bib13
  article-title: Pseudoexfoliation in the Reykjavik Eye Study: prevalence and related ophthalmological variables
  publication-title: Acta Ophthalmol Scand
  doi: 10.1111/j.1600-0420.2007.01051.x
– volume: 97
  start-page: 1215
  year: 2013
  ident: 10.1016/j.ajo.2019.10.003_bib34
  article-title: Cognitive function and pseudoexfoliation syndrome. The Beijing Eye Study 2011
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjophthalmol-2012-301906
– volume: 14
  start-page: e0211186
  year: 2019
  ident: 10.1016/j.ajo.2019.10.003_bib18
  article-title: Axial length and its associations in a Russian population: the Ural Eye and Medical Study
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0211186
– volume: 120
  start-page: 1551
  year: 2013
  ident: 10.1016/j.ajo.2019.10.003_bib16
  article-title: Pseudoexfoliation: normative data and associations. The Beijing Eye Study 2011
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2013.01.020
– volume: 40
  start-page: 454
  year: 2012
  ident: 10.1016/j.ajo.2019.10.003_bib29
  article-title: Prevalence of pseudoexfoliation syndrome in indigenous Australians within central Australia: the Central Australian Ocular Health Study
  publication-title: Clin Experiment Ophthalmol
  doi: 10.1111/j.1442-9071.2011.02696.x
– volume: 317
  start-page: 1397
  issue: 5843
  year: 2007
  ident: 10.1016/j.ajo.2019.10.003_bib2
  article-title: Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma
  publication-title: Science
  doi: 10.1126/science.1146554
– volume: 92
  start-page: 1325
  year: 2008
  ident: 10.1016/j.ajo.2019.10.003_bib14
  article-title: Pseudoexfoliation in a rural Burmese population: the Meiktila Eye Study
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.2008.141523
– volume: 204
  start-page: 130
  year: 2019
  ident: 10.1016/j.ajo.2019.10.003_bib19
  article-title: Intraocular pressure and its associations in a Russian population: the Ural Eye and Medical Study
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2019.02.030
– volume: 14
  start-page: e0215636
  year: 2019
  ident: 10.1016/j.ajo.2019.10.003_bib21
  article-title: Prevalence, awareness and control of diabetes in Russia: the Ural Eye and Medical Study on adults aged 40+ years
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0215636
– volume: 93
  start-page: 162
  year: 2015
  ident: 10.1016/j.ajo.2019.10.003_bib40
  article-title: Pseudoexfoliation and mortality: a population-based 30-year follow-up study
  publication-title: Acta Ophthalmol
  doi: 10.1111/aos.12402
– volume: 3
  start-page: 176
  year: 1994
  ident: 10.1016/j.ajo.2019.10.003_bib7
  article-title: Exfoliation syndrome–the most common identifiable cause of open-angle glaucoma
  publication-title: J Glaucoma
  doi: 10.1097/00061198-199400320-00018
– volume: 122
  start-page: 1873
  year: 2015
  ident: 10.1016/j.ajo.2019.10.003_bib26
  article-title: Fundus tessellation: prevalence and associated factors. The Beijing Eye Study 2011
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2015.05.031
– volume: 71
  start-page: 1269
  year: 2018
  ident: 10.1016/j.ajo.2019.10.003_bib23
  publication-title: Hypertension
  doi: 10.1161/HYP.0000000000000066
– volume: 86
  start-page: 238
  year: 2002
  ident: 10.1016/j.ajo.2019.10.003_bib28
  article-title: The definition and classification of glaucoma in prevalence surveys
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.86.2.238
– volume: 129
  start-page: 1053
  year: 2011
  ident: 10.1016/j.ajo.2019.10.003_bib30
  article-title: Geographic and climatic factors associated with exfoliation syndrome
  publication-title: Arch Ophthalmol
  doi: 10.1001/archophthalmol.2011.191
– volume: 14
  start-page: 482
  year: 2005
  ident: 10.1016/j.ajo.2019.10.003_bib12
  article-title: The prevalence of pseudoexfoliation syndrome in a Japanese population: the Hisayama study
  publication-title: J Glaucoma
  doi: 10.1097/01.ijg.0000185436.15675.b3
– volume: 120
  start-page: 844
  year: 2013
  ident: 10.1016/j.ajo.2019.10.003_bib27
  article-title: Clinical classification of age-related macular degeneration
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2012.10.036
SSID ssj0006747
Score 2.441333
Snippet To assess the prevalence of pseudoexfoliation (PEX) and its associations in a Russian population. Population-based cross-sectional study. Setting: Ufa capital...
PurposeTo assess the prevalence of pseudoexfoliation (PEX) and its associations in a Russian population.DesignPopulation-based cross-sectional...
To assess the prevalence of pseudoexfoliation (PEX) and its associations in a Russian population.PURPOSETo assess the prevalence of pseudoexfoliation (PEX) and...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 158
SubjectTerms Adult
Age
Age Distribution
Aged
Aged, 80 and over
Blood pressure
Cataracts
Cross-Sectional Studies
Diabetes
Ethnicity
Exfoliation Syndrome - epidemiology
Exfoliation Syndrome - etiology
Eye surgery
Female
Glaucoma
Humans
Male
Middle Aged
Prevalence
Risk Factors
Rural Population - statistics & numerical data
Russia - epidemiology
Secondary education
Urban Population - statistics & numerical data
Title Prevalence and Associated Factors of Pseudoexfoliation in a Russian Population: The Ural Eye and Medical Study
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0002939419304921
https://dx.doi.org/10.1016/j.ajo.2019.10.003
https://www.ncbi.nlm.nih.gov/pubmed/31606443
https://www.proquest.com/docview/2348269223
https://www.proquest.com/docview/2305473513
Volume 210
WOSCitedRecordID wos000512216200019&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals 2021
  customDbUrl:
  eissn: 1879-1891
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0006747
  issn: 0002-9394
  databaseCode: AIEXJ
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jj9MwFLY6MwhxQaxDYRgZCXEApWoSJ064DahlK2UErVRxiRzHVtekdFOHv8cf4zmxE4ZqChy4RFESu43fl-e3P4SeerZPRUilxYIgtkjiE4vxOLYodxl3ZRzTJK-u36HdbjAYhOe12g-TC7OZ0jQNtttw_l9JDdeA2Cp19h_IXU4KF-AciA5HIDsc_4rwqigTy1OJcseAWX8QLNu6t44Ke1uKdZKJrcymBW2U3YO9-Lxe5kmV52VbLxOV0VeJ_K0LHZihvTtfytq0po6t8f_8UpAimw9XQzadXbLfvxpN4myTW2PXkyFbLNissst-ZaNU-ah05n_KVtW9N6PpjKkQs1Qjbb2oYh4_sO9sEjN4_9zcf6Em0UO1YQO02OalIJEy42Y300tx8dAtmiM3RMG4AxpadlB0_jKc3dERswVvtosa8Tt7RmG-GDfYWCWD2mEjj_Zzqw3SBAV0P0XtfqcT9VqD3rP5N0u1LlMuft3H5QAdOdQLgbUenb1rDd6XAoFPCTVamPrbxrmehxn-9qtXiUdXqT-5GNS7hW5q_QWfFbi7jWoivYOuf9QRGndRWsEPA1RwBT-s4YcziXfgh0cpZljDD1fwe4kBfFiBDwP48hk1-HAOvnuo3271Xr-1dE8Pi5OQrizPi6XDgG9IIuMkcYgIm37CAyntkMQ2E8A8OPPUbS5graTHXQ5nHgPNtykd9z46TLNUPEA4VtqCm_guZ4mqKxkI4XicsJi40qFE1FHTLGXEdcF71XdlGpnIxnEEqx-p1VeXYPXr6Hk5ZF5Ue9n3sGPoE5k0Zth4I8DVvkGkHKRl3EJ2_dOwEwOASH_By8hRhan8EAT8OnpS3obtQfn8WCqytXqmmXcXt-GZ4wI45Zu5tg8KCXEf7p_8EbpRfZ4n6HC1WIvH6BrfrEbLxSk6oIPgVEP-JyfJ5-4
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+and+Associated+Factors+of+Pseudoexfoliation+in+a+Russian+Population%3A+The+Ural+Eye+and+Medical+Study&rft.jtitle=American+journal+of+ophthalmology&rft.au=Bikbov%2C+Mukharram+M&rft.au=Zainullin%2C+Rinat+M&rft.au=Gilmanshin%2C+Timur+R&rft.au=Kazakbaeva%2C+Gyulli+M&rft.date=2020-02-01&rft.pub=Elsevier+Limited&rft.issn=0002-9394&rft.eissn=1879-1891&rft.volume=210&rft.spage=158&rft_id=info:doi/10.1016%2Fj.ajo.2019.10.003&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9394&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9394&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9394&client=summon